SCHEMBL3671936

SCHEMBL3671936

O=CNCCS

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16085342 0.81
SCHEMBL3197403 0.78
SCHEMBL8068062 0.74 ADH1B (0.71)
SCHEMBL10892758 0.74 HDAC3 (0.43)
SCHEMBL499577 0.73
SCHEMBL5860428 0.72
SCHEMBL11467304 0.72 ADH1B (0.56)
SCHEMBL8764004 0.72 ADH1B (0.72)
SCHEMBL11322360 0.72 ADH1B (0.72)
SCHEMBL8763225 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9487494-B2 Cyclic hydrocarbon compounds for the treatment of diseases LEO PHARMA A/S (DK) 2016-11-08 US claimed
US-20100317582-A1 NOVEL CYCLIC HYDROCARBON COMPOUNDS FOR THE TREATMENT OF DISEASES LEO PHARMA A/S (DK) 2010-12-16 US claimed
EP-2234961-A2 NOVEL CYCLIC HYDROCARBON COMPOUNDS FOR THE TREATMENT OF DISEASES LEO PHARMA A/S (DK) 2010-10-06 EP claimed
WO-2009065406-A2 NOVEL CYCLIC HYDROCARBON COMPOUNDS FOR THE TREATMENT OF DISEASES LEO PHARMA A/S (DK) 2009-05-28 WO claimed
US-20220323591-A1 HEPARIN NANO DRUG CARRIER SYSTEM LOADED WITH AMINO ANTI-TUMOR DRUG AND PREPARATION METHOD THEREOF NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL CO., LTD. (CN) 2022-10-13 US disclosed
US-11160871-B2 SSTR-targeted conjugates and particles and formulations thereof TARVEDA THERAPEUTICS, INC. (US) 2021-11-02 US disclosed
US-10624967-B2 Targeted conjugates and particles and formulations thereof TARVEDA THERAPEUTICS, INC. (US) 2020-04-21 US disclosed
US-20180221499-A1 SSTR-TARGETED CONJUGATES AND PARTICLES AND FORMULATIONS THEREOF TVA (ABC), LLC 2018-08-09 US disclosed
WO-2018042367-A2 COMPOUNDS, COMPOSITONS AND METHODS RELATED TO ANTIMICROBIAL APPLICATIONS VYOME BIOSCIENCES PVT. LTD. (IN) 2018-03-08 WO disclosed
US-20170135970-A1 N-ACETYLCYSTEINE AMIDE (NAC AMIDE) IN THE TREATMENT OF DISEASES AND CONDITIONS ASSOCIATED WITH OXIDATIVE STRESS GOLDSTEIN GLENN A (US) 2017-05-18 US disclosed
US-9487494-B2 Cyclic hydrocarbon compounds for the treatment of diseases LEO PHARMA A/S (DK) 2016-11-08 US disclosed
US-9452392-B2 Gas separation composite membrane and method of producing the same, and gas separating module, gas separation apparatus and gas separation method using the same FUJIFILM CORPORATION (JP) 2016-09-27 US disclosed
US-RE30560-E VINCRISTINE SUBSTITUTES; ANTITUMOR AGENTS ELI LILLY AND COMPANY (US) 1981-03-31 US disclosed
US-RE30561-E ANTITUMOR AGENTS ELI LILLY AND COMPANY (US) 1981-03-31 US disclosed
US-4256767-A Phenoxy alkylamides SOCIETE D'ETUDES DE PRODUITS CHIMIQUES (FR) 1981-03-17 US disclosed
US-4203898-A ANTICARCINOGENIC ELI LILLY AND COMPANY (US) 1980-05-20 US disclosed
US-4199504-A ANTITUMOR AGENTS, ANTICARCINOGENIC AGENTS ELI LILLY AND COMPANY (US) 1980-04-22 US disclosed
EP-0005620-A1 Bridged catharanthus alkaloid dimers, their preparation and formulations containing them ELI LILLY AND COMPANY (US) 1979-11-28 EP disclosed
US-4160767-A 3-SPIRO-5\"-OXAZOLIDINE-2\",4\"-DIONES, ANTITUMOR AGENTS, 3-CARBAMATES ELI LILLY AND COMPANY (US) 1979-07-10 US disclosed
US-4096148-A ANTITUMOR AGENTS ELI LILLY AND COMPANY (US) 1978-06-20 US disclosed